The Claim
Dynamic adrenal function testing with ACTH stimulation is necessary to accurately assess adrenal suppression in cancer patients receiving intermittent high-dose dexamethasone because single morning cortisol measurements lack diagnostic precision in this population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In cancer patients taking intermittent high-dose dexamethasone, adrenal suppression can only be accurately measured using ACTH stimulation tests; morning cortisol levels alone are not precise enough.
See the scientific wording
Dynamic adrenal function testing with ACTH stimulation is necessary to accurately assess adrenal suppression in cancer patients receiving intermittent high-dose dexamethasone, as single morning cortisol measurements lack diagnostic precision in this context.
High-dose dexamethasone binds to receptors in the brain and pituitary, stopping the signals that tell the adrenal glands to make cortisol. Without these signals, the adrenal glands produce less cortisol, and a single morning cortisol test cannot show if the glands are still able to respond when needed.
What the research says
1 studyThe study found that checking cortisol just once in the morning isn’t reliable enough to tell if chemotherapy and dexamethasone have shut down the adrenal glands. The researchers say we need better tests—like giving a hormone to see how the adrenal glands respond—to get a clearer picture.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.